Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. [electronic resource]
Producer: 20150728Description: 1102-9 p. digitalISSN:- 1468-2060
- Adipokines -- metabolism
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- diagnostic imaging
- Biomarkers -- metabolism
- C-Reactive Protein -- metabolism
- Chitinase-3-Like Protein 1
- Disease Progression
- Drug Therapy, Combination
- Epidermal Growth Factor -- metabolism
- Female
- Foot Joints -- diagnostic imaging
- Hand Joints -- diagnostic imaging
- Humans
- Hydroxychloroquine -- therapeutic use
- Infliximab
- Interleukin-6 -- metabolism
- Lectins -- metabolism
- Leptin -- metabolism
- Logistic Models
- Male
- Matrix Metalloproteinase 1 -- metabolism
- Matrix Metalloproteinase 3 -- metabolism
- Methotrexate -- therapeutic use
- Multivariate Analysis
- Prognosis
- Radiography
- Receptors, Tumor Necrosis Factor, Type I -- metabolism
- Resistin -- metabolism
- Serum Amyloid A Protein -- metabolism
- Severity of Illness Index
- Sulfasalazine -- therapeutic use
- Treatment Outcome
- Vascular Cell Adhesion Molecule-1 -- metabolism
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.